Compare ACADIA Pharmaceuticals Inc. (ACAD) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ACADIA Pharmaceuticals Inc. vs J B Hunt Transport Services Inc — how do they compare? ACADIA Pharmaceuticals Inc. trades at $25.99 (market cap $4.49B), while J B Hunt Transport Services Inc trades at $276.45 (market cap $25.93B). The key difference: J B Hunt Transport Services Inc is far larger — about 5.8× ACADIA Pharmaceuticals Inc.'s market cap, and J B Hunt Transport Services Inc pays a 0.65% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | JBHT | |
|---|---|---|
Market Cap | $4.49B | $25.93B |
Sector | Health | Industrials |
52-Week High | $28.06 | $290.07 |
52-Week Low | $20.06 | $130.65 |
Enterprise Value | $3.69B | $27.23B |
Dividend Yield | — | 0.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
JBHT trades at $275.00, down 3.79% over 24 hours, with a bullish technical signal from moving averages and a neutral stance from oscillators. The company reported revenue of $12.00 billion in 2025 with a net income margin of 5.13%, and has beaten earnings estimates for the last three quarters. Recent news highlights its participation in industry conferences and positive analyst coverage amid a improving freight scenario.
The outlook for JBHT is supported by consistent earnings beats and a favorable analyst consensus, though high valuation ratios and exposure to freight market cyclicality present risks. Upside potential exists if the company maintains operational efficiency and capitalizes on industry tailwinds, but investors should weigh elevated P/E and P/B multiples against growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ACADIA Pharmaceuticals Inc.
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
